lobbying_activities: 3049511

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3049511	fdfee02a-1e44-4535-ba73-cf0706c959f2	Q3	DRUG POLICY ALLIANCE	68651	DRUG POLICY ALLIANCE	2023	third_quarter	LAW	Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)	HOUSE OF REPRESENTATIVES,SENATE		87644	0	0	2023-10-13T16:28:16-04:00